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Important Announcements
1. Board Elects New President and Secretary: On Decem-
ber 16, 2003, the Massachusetts Board of Registration in 
Pharmacy elected James T. DeVita, RPh, president and Karen 
Ryle, MS, RPh, secretary.
2. Donna M. Horn President-Elect of NABP®: At the National 
Assocation of Boards of Pharmacy's (NABP®) 99th Annual 
Meeting in 2003, Donna M. Horn, RPh, past president of the 
Board of Pharmacy, was elected president-elect of NABP and 
will go on to serve as its 100th president following the 100th 
Annual Meeting in Chicago, IL, April 24-27, 2004.
3.  Update on Electronic Prescriptions: As a result of recent 
passage of a Uniform Electronic Transaction Act (Senate 
2076) in Massachusetts, the Board of Registration in Phar-
macy (Board) and Department of Public Health (Department) 
have revised regulations allowing electronic transmission of 
certain prescriptions for Schedule VI controlled substances. 
According to the new rules, prescribers will have to abide 
by new Department regulations at 105 CMR 720.000 et seq. 
These regulations set the format, security, and confidentiality 
standards for prescriptions in Massachusetts and can be found 
on the Department Web site at www.state.ma.us/dph/dcp/ 
dcp.htm. Revisions to Board Regulations, effective February 
27, 2004 (247 CMR, section 5.02), can be found by visiting 
the Board’s Web site at www.state.ma.us/reg/boards/ph/cmr_
dr/2004_prop_reg.pdf. 
4. Board Develops Ambulatory Root Cause Analysis (RCA) 
Tool as an Educational and Patient Safety Initiative: On 
February 10, 2004, following months of research, the Board 
reviewed a tool for use by the regulated community that will 
assist in responding to Quality Related Events (QRE). A QRE 
is defined as any departure from the appropriate dispensing of 
a prescribed medication that is not corrected prior to delivery 
of the medication. This RCA Tool was designed to assist reg-
istrants in the process of assessing and preventing QREs. For 
further information about the complete report and analysis 
tool, please visit the Board Web site. 
5. Board Proposes Regulations to Require Quality Assur-
ance Standards in Retail Pharmacies: As part of its patient 
safety initiatives, the Board is proposing quality assurance 
(QA – continuing quality improvement) regulations that will 
require every Massachusetts-licensed pharmacy to have writ-
ten policies and procedures in place that must be established 
“for the purpose of detecting, documenting, assessing and 
preventing Quality-Related Events. . . .” The regulations will 
also require annual professional education in the area of QA 
for pharmacists, registered technicians, and registered interns.
6. USP Announces New Standard: Pharmacists should be 
reminded that Board regulations [247 CMR, 9.01 (3)] state: “a 
pharmacist shall observe the standards of the current United 
States Pharmacopoeia [USP].” Pharmacists are likely aware 
that USP has issued new standards: “Standard 797 Pharma-
ceutical Compounding – Sterile Preparations,” which became 
effective January 1, 2004. Pharmacists in all regulated practice 
settings are expected to follow this standard when compound-
ing sterile preparations. For instructions on obtaining a copy 
of the standard, visit USP’s Web site at www.usp.org.
7. NABP and FDA Form Alliance in Attacking the Problem 
of Counterfeit Drugs: On February 18, 2004, United States 
Department of Health and Human Services Secretary (HHS) 
Tommy Thompson, Food and Drug Administration (FDA) 
Commissioner Mark McClellan, and NABP Executive Direc-
tor/Secretary Carmen A. Catizone, MS, RPh, DPh, held a 
joint press conference to announce FDA’s Task Force Report 
on counterfeit drugs, “Combating Counterfeit Drugs” (www.
fda.gov/oc/initiatives/counterfeit/report02_04.html) NABP 
and FDA have joined forces in dealing with this emerging 
threat and NABP has developed new model regulations for 
the licensing of drug wholesalers that NABP and FDA are 
asking member boards of pharmacy to adopt. These model 
regulations will require appropriate background checks of key 
employees, and electronic tracking requirements by 2007, 
called “pedigrees,” which trace the movement of prescrip-
tion drugs from manufacture to dispensing. NABP will also 
develop a clearinghouse of information on these wholesalers 
and has provided a list of drugs most suspected of being cop-
ied by clandestine operations. For further information, visit 
NABP’s Web site at www.nabp.net.
8. From the President – James T. DeVita, RPh: It is our Mis-
sion at the Board of Pharmacy to promote, preserve, and protect 
the health, safety, and welfare of the citizens of the Com-
monwealth by fostering the delivery of quality pharmaceutical 
care. To accomplish this Mission, the Board must assume a 
leadership role in regulating the practice of pharmacy and act in 
accordance with the highest standards of ethics, accountability, 
efficiency, effectiveness, and open communication.
 In 2004, the Board of Pharmacy will focus its resources on 
goals that will advance patient safety, reduce pharmacist 
workload, and improve communication with its registrants. 
Initiatives such as electronic prescribing, collaborative practice, 
pharmacist immunization, compounding guidelines, and con-
tinuous quality improvement regulations are well underway. 
 The purpose of this quarterly Newsletter is to offer infor-
mation regarding the latest developments within the Board 
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and provide direction to additional informational resources. 
Future Newsletters will highlight specific areas of interest and 
offer guidance for new initiatives. 
 As the profession continues to evolve, timely communica-
tion will be a vital component to the success of the practice 
of pharmacy. I encourage registrants to read the Newsletters, 
visit our Web site, and attend our public Board meetings.
9. Quality Assurance – Recent Cases Reviewed by the Board: 
Look-alike/Sound-alike Drugs: Be Aware
 Keppra®/Kaletra®
 Metaproterenol/Metoprolol 
 Clonidine/Colchicine 
 Mysoline®/Minocin® 
 Seroquel®/Serzone® 
 Zantac®/Zyrtec®
 Zestril®/Zerit®
 Clomiphene/Clomipramine 
10. Best Practice Recommendation of the Month: As you are 
likely aware, the Board developed a set of 21 Best Practice 
Recommendations in 2003 that the Board believes may assist 
in reducing medication errors, improving the quality of drug 
delivery, and optimizing patient outcomes. These recommen-
dations may be found on the Board’s Web site at  
www.state.ma.us/reg/boards/ph/misc/bprac.htm. The Board 
finds pediatric medication errors of particular concern and 
this month’s Newsletter will feature Best Practice Recom-
mendation No. 8, which recommends: “Utilize available 
age-adjusted dosing guidelines when appropriate.”
Recommended Actions 
 ♦ Verify pediatric dosing to ensure proper dose. 
 ♦ Develop pediatric- and geriatric-specific guidelines for 
age-adjusted dosing. 
 ♦ Consider acquiring or utilizing reference materials, 
textbooks, and/or computer software that directly address 
pediatric and geriatric dosing. 
 ♦ When appropriate and necessary, verify that doses are 
appropriate for the patient. 
 In addition, the Board strongly recommends (as set forth in Best 
Practice Recommendation No. 6) that the pharmacist make an 
attempt to counsel on each pediatric new and refill prescription. 
11. HHS Announces New Requirements for Bar Codes on 
Drugs and Blood to Reduce Risk of Medication Errors:
 On February 25, 2004, HHS Secretary Tommy Thompson 
announced that FDA issued a final rule requiring bar codes 
on the labels of thousands of human drugs and biological 
products. This final rule will require linear bar codes on most 
prescription drugs and on over-the-counter drugs commonly 
used in hospitals and dispensed pursuant to an order. For 
blood and blood components intended for transfusion, the 
final rule requires the use of machine-readable information in 
a format approved for use by FDA. For a complete copy of 
the report and press release, visit the following link:  
www.fda.gov/oc/initiatives/barcode-sadr/. 
Recent Board Policies 
For a complete list of all Board policies visit our Web site at: 
♦ www.state.ma.us/reg/boards/ph/default.htm
♦ www.state.ma.us/reg/boards/ph/pol00000.htm
Please consider providing feedback to the Board about your com-
ments/suggestions about this and future Newsletters. Remember, 
this Newsletter is for you, so feel free to send recommendations 
for future Newsletters by e-mail to charles.r.young@state.ma.us or 
james.d.coffey@state.ma.us.
Thank you.
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